During the past decade, Ospedale Alessandro Manzoni conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 13 clinical trials were completed, i.e. on average, 185.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Alessandro Manzoni" #1 sponsor was "National Cancer Institute, Naples" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "University of Milano Bicocca" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Alessandro Manzoni" #1 collaborator was "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Alessandro Manzoni" are "Breast Cancer" (7 trials), "Ovarian Cancer" (4 trials), "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials) and "Tachycardia" (2 trials). Many other conditions were trialed in "Ospedale Alessandro Manzoni" in a lesser frequency.

Most popular intervention types in "Ospedale Alessandro Manzoni" are "Drug" (25 trials), "Device" (7 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials) and "NovoTTF-100A device" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Alessandro Manzoni" are 26 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Alessandro Manzoni". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Ospedale Alessandro Manzoni, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Alessandro Manzoni, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".